Eisai Drops Numbers from New Mid-Term Plan; CEO Wants Value-Based Pricing for AD Meds

March 29, 2021
Eisai on March 26 unveiled its new mid-term business plan beginning in FY2021, which revolves around the company’s broad strategic policies to address changes in the industry environment with no numerical targets provided. In the new plan, dubbed EWAY Future...read more